| Trial ID: | L7301 |
| Source ID: | NCT03999853
|
| Associated Drug: |
Bkr-017
|
| Title: |
Butyrate Adjuvant Therapy for Type 1 Diabetes
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type1diabetes
|
| Interventions: |
DRUG: BKR-017
|
| Outcome Measures: |
Primary: Insulin sensitivity, Change in Insulin sensitivity, (Day 0) to Day 28 and Day 56 | Secondary: Glucose Variability and Triglycerides, Changes in glucose measurements and triglycerides, (Day 0) to Day 28 and Day 56
|
| Sponsor/Collaborators: |
Sponsor: Mayo Clinic | Collaborators: BioKier Inc.|Juvenile Diabetes Research Foundation
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2022-07-28
|
| Completion Date: |
2025-04
|
| Results First Posted: |
|
| Last Update Posted: |
2024-11-08
|
| Locations: |
Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03999853
|
